Cannara Biotech Inc. LOVE.TO
TSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.53M | 1.21M | 744.60K | 2.42M | 2.95M |
| Total Depreciation and Amortization | 1.19M | 952.80K | 1.13M | 1.63M | 899.50K |
| Total Amortization of Deferred Charges | -- | 85.40K | 34.40K | 36.90K | -- |
| Total Other Non-Cash Items | 1.15M | 1.86M | 3.91M | 1.01M | 1.40M |
| Change in Net Operating Assets | -1.73M | -1.96M | -117.00K | -3.03M | 4.65M |
| Cash from Operations | 4.14M | 2.15M | 5.70M | 2.06M | 9.89M |
| Capital Expenditure | -3.21M | -2.35M | -3.31M | -1.07M | -1.57M |
| Sale of Property, Plant, and Equipment | -- | 101.90K | -- | 102.10K | 11.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.92M | 64.20K | 42.70K | 60.30K | 38.70K |
| Cash from Investing | -5.12M | -2.19M | -3.27M | -906.30K | -1.52M |
| Total Debt Issued | 2.00M | -- | -- | 0.00 | -- |
| Total Debt Repaid | -130.00K | -658.60K | -654.40K | -655.10K | -1.67M |
| Issuance of Common Stock | -- | 6.30M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -606.00K | -197.90K | -590.80K | -976.40K | -747.80K |
| Cash from Financing | 920.10K | 3.96M | -892.00K | -1.19M | -1.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.60K | 3.92M | 1.55M | -34.70K | 6.65M |